No change has been made to the classification of codeine, but the Medicines Classification Committee (MCC) has posed some questions to the sector that it must answer if some codeine products are to remain pharmacist-only.
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes